|Programs + Specialties
|Training + Education
Tulane University School of Medicine; Stanford University; Johns Hopkins University School of Medicine
Tufts Medical Center
South Building, 6th Floor
800 Washington Street
Boston, MA 02111
Fax #: 617-636-7175
Phone #: 617-636-8066
2016, NIH Great Teachers Lecture, Bethesda, MD
2014, Honoree for Clinical & Research Achievement in Hypertrophic Cardiomyopathy, Minneapolis Heart Institute Foundation Gala, Minneapolis, MN
2014, Coeur d' Or Award, Kalra Hospital, New Delhi, India and World Heart Federation, Geneva, Switzerland
2012, Simon Dack Award for Outstanding Scholarship, American College of Cardiology, Chicago, IL
2010, Edward Flanders Ricketts Award, in recognition of outstanding contribution to the field of cardiovascular medicine, Monterey, CA
2011, Israel Heart Society. Henry Neufeld Distinguished Lectureship, Tel Aviv, Israel
2010, Japanese Circulation Society. For contributions to the progress and development of hypertrophic cardiomyopathy in Japan, Kyoto, Japan
2008, American College of Cardiology, Distinguished Clinical Scientist Career Award, Chicago, IL
2008, Life achievement award for dedication and guidance in the field of cardiomyopathies. European Myocardial and Pericardial Working Group of the European Society of Cardiology, Florence, Italy
2007, Physician’s Heart and Stroke Award for outstanding research and commitment to the areas of hypertrophic cardiomyopathy and sudden death in athletes. American Heart Association, Minneapolis, MN
1. Maron BJ, Maron MS. LGE means better selection of HCM patients for primary prevention implantable defibrillators. J Am Coll Cardiol: Cardiovascular Imaging. 2016, July 14.
2. Maron BJ, Maron MS. The remarkable 50 years of imaging in hypertrophic cardiomyopathy and how it has changed diagnosis and management: from M-mode echocardiography to cardiovascular magnetic resonance. J Am Coll Cardiol Cardiovascular Imaging. 2016;9:858-872.
3. Maron BJ, Roberts WC. The father of the ventricular septal myectomy operation for obstructive hypertrophic cardiomyopathy . . . himself had familial hypertrophic cardiomyopathy: the almost unbelievable story of the Morrow family. J Am Coll Cardiol. 2016;67:2900-2903.
4. Link MS, Bockstall K, Weinstock J, Alsheikh-Ali AA, Semsarian C, Estes NAM III, Spirito P, Haas TS, Rowin EJ, Maron MS, Maron BJ. Ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy: triggers, treatment and implications. Submitted.
5. Adalsteinsdottir B, Gardarsdottir M, Palsson R, Teekakirikul P, Maron MS, Appelbaum E, Maron BJ, Voldorff Madsen C, Burke, MA, Danielsen R, Desnick R, Feldt-Rasmussen U, Seidman JG, Seidman CE, Gunnarsson G. Fabry disease in families with hypertrophic cardiomyopathy. Clinical manifestations of two GLA sequence variants. Submitted.
6. Kalra A, Harris KM, Baron BA, Maron MS, Garberich RF, Haas TS, Lesser JR, Maron BJ. Relation of Doppler tissue imaging parameters with heart failure progression in hypertrophic cardiomyopathy. Am J Cardiol. 2016;117:1808-1814.
7. Maron MS, Rowin EJ, Olivotti I, Casey SA, Arretini A, Tomberli B, Gerberich RF, Link MS, Chan RH, Lesser JR, Maron BJ. contemporary natural history and management of nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2016;67:1399-1409.
8. Maron BJ. Saving lives one at a time. JAMA Cardiol.2016;1:387-388.
9. Maron BJ, Rowin EJ, Casey SA, Maron MS. How hypertrophic cardiomyopathy became a contemporary treatable genetic disease with low mortality: shaped by 50 years of clinical research and practice. JAMA Cardiol. 2016;1:98-105.
10. Williams LK, Chan RH, Carasso S, Durand M, Misurka J, Crean AM, Ralph-Edwards A, Gruner C, Woo A, Lesser JR, Maron MS, Rakowski H. Effect of left ventricular outflow tract obstruction on left atrial mechanics in hypertrophic cardiomyopathy. Biomed Res Int. 2015;2015:481245.
Barry J. Maron, MD is the Director of Clinical Research in the Hypertrophic Cardiomyopathy Center at Tufts Medical Center. Previously, Dr. Maron was the Director of the Hypertrophic Cardiomyopathy Center program at the Minneapolis Heart Institute Foundation for 23 years. Prior to that, he was Senior Investigator in the National Institutes of Health (National Heart, Lung and Blood Institute) Cardiology Branch for 21 years.
Dr. Maron has authored 930 original peer-reviewed articles, book chapters and other contributions to the literature, as well as 325 abstracts and five books, including the well-regarded “Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians.” His research initiatives have included diverse clinical and pathologic aspects of hypertrophic cardiomyopathy over a 40 year career, including development of risk stratification guidelines and introducing implantable defibrillators for effective prevention of sudden death in adults and children with hypertrophic cardiomyopathy.
American College of Cardiology
American College of Sports Medicine
American Heart Association
European Society of Cardiology
Heart Rhythm Society
The Society for Pediatric Research American Heart Association, Council on Clinical Cardiology